Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
435.45
Change Change %
1.70 0.39%

Updated:19 Sep, 2018, 15:57 PM IST

BSE
434.65
Change Change %
-0.40 -0.09%

Updated:19 Sep, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Motilal Oswal
N/A
17-01-2018 Buy 547.65 651.00
N/A
Open Long (1Y)
17-01-2019

Motilal Oswal Recommends 'Buy' On Laurus Labs



According to Motilal Oswal, in addition to strong base business of API manufacturing under antiretrovirals and Hepatitis C category, Laurus Labs is forward integrating to formulations for regulated markets. The company is also forward integrating in ARVs (antiretrovirals) for further improvement in profitability, the brokerage adds. 

Top